5544.5000 49.50 (0.90%)
NSE Sep 23, 2025 15:48 PM
Volume: 240.2K
 

5544.50
0.90%
ICICI Securities Limited
Alkem Laboratories’ CEO, Dr. Vikas Gupta, is targeting double-digit revenue growth in the medium term, driven by strong hold in India (68% of sales), other international markets and new ventures.
Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended